Literature DB >> 21536666

Mechanisms of urokinase plasminogen activator (uPA)-mediated atherosclerosis: role of the uPA receptor and S100A8/A9 proteins.

Stephen D Farris1, Jie Hong Hu, Ranjini Krishnan, Isaac Emery, Talyn Chu, Liang Du, Michal Kremen, Helén L Dichek, Elizabeth Gold, Stephen A Ramsey, David A Dichek.   

Abstract

Data from clinical studies, cell culture, and animal models implicate the urokinase plasminogen activator (uPA)/uPA receptor (uPAR)/plasminogen system in the development of atherosclerosis and aneurysms. However, the mechanisms through which uPA/uPAR/plasminogen stimulate these diseases are not yet defined. We used genetically modified, atherosclerosis-prone mice, including mice with macrophage-specific uPA overexpression and mice genetically deficient in uPAR to elucidate mechanisms of uPA/uPAR/plasminogen-accelerated atherosclerosis and aneurysm formation. We found that macrophage-specific uPA overexpression accelerates atherosclerosis and causes aortic root dilation in fat-fed Ldlr(-/-) mice (as we previously reported in Apoe(-/-) mice). Macrophage-expressed uPA accelerates atherosclerosis by stimulation of lesion progression rather than initiation and causes disproportionate lipid accumulation in early lesions. uPA-accelerated atherosclerosis and aortic dilation are largely, if not completely, independent of uPAR. In the absence of uPA overexpression, however, uPAR contributes modestly to both atherosclerosis and aortic dilation. Microarray studies identified S100A8 and S100A9 mRNA as the most highly up-regulated transcripts in uPA-overexpressing macrophages; up-regulation of S100A9 protein in uPA-overexpressing macrophages was confirmed by Western blotting. S100A8/A9, which are atherogenic in mice and are expressed in human atherosclerotic plaques, are also up-regulated in the aortae of mice with uPA-overexpressing macrophages, and macrophage S100A9 mRNA is up-regulated by exposure of wild-type macrophages to medium from uPA-overexpressing macrophages. Macrophage microarray data suggest significant effects of uPA overexpression on cell migration and cell-matrix interactions. Our results confirm in a second animal model that macrophage-expressed uPA stimulates atherosclerosis and aortic dilation. They also reveal uPAR independence of these actions and implicate specific pathways in uPA/Plg-accelerated atherosclerosis and aneurysmal disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21536666      PMCID: PMC3121410          DOI: 10.1074/jbc.M110.202135

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  63 in total

1.  Overexpression of urokinase by plaque macrophages causes histological features of plaque rupture and increases vascular matrix metalloproteinase activity in aged apolipoprotein e-null mice.

Authors:  Jie Hong Hu; Liang Du; Talyn Chu; Goro Otsuka; Nagadhara Dronadula; Mia Jaffe; Sean E Gill; William C Parks; David A Dichek
Journal:  Circulation       Date:  2010-03-29       Impact factor: 29.690

2.  Co-localization of fibrinolytic activators and inhibitors with macrophages in atherosclerotic vessels.

Authors:  M Falkenberg; T Björnheden; P Lindnér; B Risberg
Journal:  Cardiovasc Pathol       Date:  1998 Jul-Aug       Impact factor: 2.185

Review 3.  Lipoprotein size and atherosclerosis susceptibility in Apoe(-/-) and Ldlr(-/-) mice.

Authors:  M M Véniant; S Withycombe; S G Young
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-10       Impact factor: 8.311

4.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

5.  Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study.

Authors:  M Cushman; R N Lemaitre; L H Kuller; B M Psaty; E M Macy; A R Sharrett; R P Tracy
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-03       Impact factor: 8.311

6.  Relationship of plasmin generation to cardiovascular disease risk factors in elderly men and women.

Authors:  P A Sakkinen; M Cushman; B M Psaty; B Rodriguez; R Boineau; L H Kuller; R P Tracy
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-03       Impact factor: 8.311

Review 7.  Extracellular proteolysis in the development and progression of atherosclerosis.

Authors:  H Roger Lijnen
Journal:  Biochem Soc Trans       Date:  2002-04       Impact factor: 5.407

8.  Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction.

Authors:  T H Bugge; M J Flick; C C Daugherty; J L Degen
Journal:  Genes Dev       Date:  1995-04-01       Impact factor: 11.361

9.  Macrophage-targeted overexpression of urokinase causes accelerated atherosclerosis, coronary artery occlusions, and premature death.

Authors:  Aaron E Cozen; Hideaki Moriwaki; Michal Kremen; Mary Beth DeYoung; Helén L Dichek; Katherine I Slezicki; Stephen G Young; Murielle Véniant; David A Dichek
Journal:  Circulation       Date:  2004-04-19       Impact factor: 29.690

10.  BABELOMICS: a suite of web tools for functional annotation and analysis of groups of genes in high-throughput experiments.

Authors:  Fátima Al-Shahrour; Pablo Minguez; Juan M Vaquerizas; Lucía Conde; Joaquín Dopazo
Journal:  Nucleic Acids Res       Date:  2005-07-01       Impact factor: 16.971

View more
  18 in total

1.  High molecular weight kininogen binds phosphatidylserine and opsonizes urokinase plasminogen activator receptor-mediated efferocytosis.

Authors:  Aizhen Yang; Jihong Dai; Zhanli Xie; Robert W Colman; Qingyu Wu; Raymond B Birge; Yi Wu
Journal:  J Immunol       Date:  2014-03-31       Impact factor: 5.422

2.  Allograft inflammatory factor-1 supports macrophage survival and efferocytosis and limits necrosis in atherosclerotic plaques.

Authors:  Lander Egaña-Gorroño; Prameladevi Chinnasamy; Isabel Casimiro; Vanessa M Almonte; Dippal Parikh; Gustavo H Oliveira-Paula; Smitha Jayakumar; Calvin Law; Dario F Riascos-Bernal; Nicholas E S Sibinga
Journal:  Atherosclerosis       Date:  2019-07-26       Impact factor: 5.162

Review 3.  S100A8 and S100A9 in cardiovascular biology and disease.

Authors:  Michelle M Averill; Claus Kerkhoff; Karin E Bornfeldt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11-17       Impact factor: 8.311

4.  Reduction of mouse atherosclerosis by urokinase inhibition or with a limited-spectrum matrix metalloproteinase inhibitor.

Authors:  Jie Hong Hu; Phanith Touch; Jingwan Zhang; Hao Wei; Shihui Liu; Ida K Lund; Gunilla Høyer-Hansen; David A Dichek
Journal:  Cardiovasc Res       Date:  2015-01-23       Impact factor: 10.787

5.  Plasmin promotes foam cell formation by increasing macrophage catabolism of aggregated low-density lipoprotein.

Authors:  Abigail S Haka; Inna Grosheva; Rajesh K Singh; Frederick R Maxfield
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-05-23       Impact factor: 8.311

6.  Urokinase receptor mediates osteogenic differentiation of mesenchymal stem cells and vascular calcification via the complement C5a receptor.

Authors:  Parnian Kalbasi Anaraki; Margret Patecki; Jan Larmann; Sergey Tkachuk; Kerstin Jurk; Hermann Haller; Gregor Theilmeier; Inna Dumler
Journal:  Stem Cells Dev       Date:  2013-12-11       Impact factor: 3.272

7.  Macrophage secretome from women with HIV-associated neurocognitive disorders.

Authors:  Krystal Colon; Juliana Perez-Laspiur; Raymond Quiles; Yolanda Rodriguez; Valerie Wojna; Scott A Shaffer; John Leszyk; Richard L Skolasky; Loyda M Melendez
Journal:  Proteomics Clin Appl       Date:  2015-11-18       Impact factor: 3.494

Review 8.  Functions of S100 proteins.

Authors:  R Donato; B R Cannon; G Sorci; F Riuzzi; K Hsu; D J Weber; C L Geczy
Journal:  Curr Mol Med       Date:  2013-01       Impact factor: 2.222

9.  Urokinase plasminogen activator and receptor promote collagen-induced arthritis through expression in hematopoietic cells.

Authors:  Sherry Thornton; Harini Raghu; Carolina Cruz; Malinda D Frederick; Joseph S Palumbo; Eric S Mullins; Kasper Almholt; Pernille A Usher; Matthew J Flick
Journal:  Blood Adv       Date:  2017-03-21

10.  Hepatic Overexpression of Soluble Urokinase Receptor (uPAR) Suppresses Diet-Induced Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (LDLR-/-) Mice.

Authors:  Jan Larmann; Kerstin Jurk; Henrike Janssen; Martin Müller; Christine Herzog; Anika Lorenz; Martina Schmitz; Jerzy-Roch Nofer; Gregor Theilmeier
Journal:  PLoS One       Date:  2015-08-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.